Legal Specialization and Board Certification Illustrates a Continued Commitment to Excellence

HOUSTON, April 9, 2025 /PRNewswire/ — Terry Bryant Accident & Injury Law proudly announces that attorney Michael Simcoe has earned Board Certification in Personal Injury Trial Law by the Texas Board of Legal Specialization (TBLS). This prestigious recognition distinguishes Simcoe as a leading force in personal injury trial law, a designation held by only a select group of attorneys in Texas. Less than 2% of licensed attorneys are Board Certified in Personal Injury Trial Law by the Texas Board of Legal Specialization.

Board Certification by the TBLS is a rigorous process that ensures attorneys meet the highest standards of competence and professionalism in their respective areas of law. To achieve this certification, attorneys must meet heightened qualifications including:

• Practice law fulltime for at least 5 years as an active member of the State Bar of Texas;
• At least 3 years of Personal Injury Trial Law experience with a yearly minimum 25% substantial involvement with Personal Injury Trial Law matters;
• Tried at least 10 Personal Injury Trial Law cases that met substantive requirements;
• Qualified vetted references from judges and lawyers in the area;
• Complete 60 hours of TBLS-approved continuing legal education in Personal Injury Trial Law;
• Meet all of the TBLS Standards for Attorney Certification; and
• Pass a comprehensive 6-hour examination on Personal Injury Trial Law.

Attorneys who earn this distinction demonstrate a commitment to legal excellence and a deep understanding of complex personal injury litigation. Initial certification is valid for 5 years, after which attorneys must apply for recertification, proving continued involvement, peer recognition, and advanced legal education in their specialty.

“Michael’s achievement is a testament to his dedication and knowledge in advocating for injured clients,” said founder and lead attorney Terry Bryant, who has been Board Certified in Personal Injury Trial Law since 1993. “Board Certification is a mark of excellence, and we are incredibly proud of his commitment to delivering exceptional legal representation.”

Michael Simcoe‘s Board Certification underscores his extensive trial experience and litigation skills handling personal injury cases, from auto accidents to workplace injuries and wrongful death claims. Michael has practiced for over 20 years and exclusively in the field of personal injury law. He has tried his more than 130 cases to verdict in courtrooms all across the state of Texas. Throughout his career, he has mentored and taught countless attorneys courtroom skills. Mr. Simcoe has also conducted seminars on the use of technology during trial for attorneys from all over the United States.

Clients seeking representation from a Board-Certified attorney can be assured they are working with a professional who has met stringent qualifications and demonstrated exceptional legal ability in personal injury trial law.

About Terry Bryant Accident & Injury Law
The Terry Bryant Accident & Injury Law has been fighting for injured victims’ rights since 1985. In that time, the firm has gained a strong reputation in the community as a trusted and experienced legal team. We offer our prospective clients free and confidential initial consultations where callers can discuss their potential legal claims. Call us now at (713) 973-8888 or toll-free 1 (800) 444-5000 to get the legal help you need.

This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/michael-simcoe-earns-board-certification-in-personal-injury-trial-law-by-the-texas-board-of-legal-specialization-302423778.html

SOURCE Terry Bryant Accident & Injury Law

See it and save it with a front-facing camera that records crystal-clear video and automatically saves it
if an incident is detected, while the headlight lights the way

OLATHE, Kan., April 9, 2025 /PRNewswire/ — Garmin (NYSE: GRMN) today announced the Varia™ Vue headlight camera, the latest addition to its lineup of accessories designed to help increase safety and visibility for cyclists riding on roadways. Complete with a 4K front-facing camera (requires memory card; not included1) that saves video automatically if an incident is detected2, plus a 600-lumen headlight, Varia Vue boasts a range of premium features to provide cyclists with greater peace of mind – all while maintaining impressive battery life. Users can also sync with the Varia RCT715 radar taillight camera (sold separately) to capture their ride from both angles. 

“With Varia Vue, cyclists can embark on rides knowing they’re more likely to be seen on the road when using the headlight and are equipped with a high-resolution camera that can capture it all. We’re thrilled to add another tool to Garmin’s unparalleled cycling lineup, giving riders the confidence they need to pursue their passion with greater peace of mind than ever before.”
–Susan Lyman, Garmin Vice President of Consumer Sales and Marketing

You ride, it records

No matter the road or route, Varia Vue’s built-in camera records sharp, 4K video while Electronic Image Stabilization keeps the footage steady. If the device detects an incident along the way, the camera automatically saves and stores video from before, during and after the event. Plus, when Varia Vue is connected via Wi-Fi®, any saved footage can be automatically uploaded to Garmin Vault for secure storage with an active subscription. At the end of a ride, cyclists can also use the Varia app to review and edit video clips.

A smarter and brighter headlight

Day and night, Varia Vue’s smart headlight illuminates the way, offering five light modes of up to 600 lumens that automatically adjust to fit a rider’s speed and surroundings when riding with a compatible Edge® cycling computer. The headlight’s smart design also includes a cutoff beam, reducing the light intensity above the cutoff line to help preserve the vision of oncoming traffic.

Other features to love

Exceptional battery life: Take the long way with up to 7 hours of battery life in day flash mode with the camera recording, and up to 9 hours when the headlight is off. And for the longest of rides, the headlight camera can be used while charging.Adjust from anywhere: For on-the-go convenience, camera and headlight settings can be changed any time from a compatible Edge cycling computer or the Varia app.Clear audio: The concealed microphone captures clean audio during every ride.Simple setup: Easily add to existing setups using Edge out-front bike mounts.

Available now, Varia Vue has a suggested retail price of $549.99. See it on display during the Sea Otter Classic at the Garmin booth, #R121.

Engineered on the inside for life on the outside, Garmin products have revolutionized life for runners, cyclists, swimmers and athletes of all levels and abilities. Committed to developing technology that helps people stay active and elevate performance, Garmin believes every day is an opportunity to innovate and a chance to beat yesterday. Visit the Garmin Newsroom, email our media team, connect with @garmincycling on social, or follow our blog.   

1 For more information, visit Garmin.com/VariaVueMemoryCard
2 Some jurisdictions regulate or prohibit use of this camera device. It is your responsibility to know and comply with applicable laws and rights to privacy in jurisdictions where you plan to use this device.

About Garmin International, Inc. Garmin International, Inc. is a subsidiary of Garmin Ltd. (NYSE: GRMN). Garmin Ltd. is incorporated in Switzerland, and its principal subsidiaries are located in the United States, Taiwan and the United Kingdom. Garmin and Edge are registered trademarks and Varia is a trademark of Garmin Ltd. or its subsidiaries. All other brands, product names, company names, trademarks and service marks are the properties of their respective owners. All rights reserved. Wi-Fi is a registered trademark of the Wi-Fi Alliance.

Notice on Forward-Looking Statements:
This release includes forward-looking statements regarding Garmin Ltd. and its business. Such statements are based on management’s current expectations. The forward-looking events and circumstances discussed in this release may not occur and actual results could differ materially as a result of known and unknown risk factors and uncertainties affecting Garmin, including, but not limited to, the risk factors listed in the Annual Report on Form 10-K for the year ended December 28, 2024, filed by Garmin with the Securities and Exchange Commission (Commission file number 0001-411180). A copy of such Form 10-K is available at http://www.garmin.com/aboutGarmin/invRelations/finReports.html. No forward-looking statement can be guaranteed. Forward-looking statements speak only as of the date on which they are made and Garmin undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

MEDIA CONTACTS:
Brianna Silverman and Natalie Miller
913-397-8200
media.relations@garmin.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/garmin-introduces-varia-vue-its-first-cycling-headlight-with-a-built-in-4k-camera-302423561.html

SOURCE Garmin International, Inc.

Health Care Industry Veteran to Lead Company’s Product Commercialization

VANCOUVER, BC, April 9, 2025 /CNW/ – Light AI Inc. (“Light AI” or the “Company”) (CBOE CA: ALGO) (FSE: 0HC) (OTCQB: OHCFF) a global healthcare technology company focused on developing artificial intelligence (AI) health diagnostic and wellness solutions, today announced that it has appointed John Tse as Vice President, Commercial Development, effective immediately.

“I am thrilled to welcome John to our team. He brings extensive knowledge of our market and the commercialization of game changing initiatives,” said Peter Whitehead, CEO of Light AI. “With his deep connections to healthcare leaders in Canada and the USA, both in the industry and government sectors, John will be a tremendous asset to our organization.”

Recognized Health Care Industry Leader

Mr. Tse has thirty years of senior corporate management and executive leadership with London Drugs, inclusive as Vice President, Pharmacy and Cosmetics, where he was a key member of its executive team advanced the company to be one of the most recognized drug store chains in Canada and within the top 20 drug store chains in North America.

With advancements in healthcare and increasing complexity in treatment options, front line practitioners need assistance to deliver the right care to the right patients at the right time with a void in the healthcare technology space; Mr. Tse, a licensed pharmacist, embarked, in 2018, on an entrepreneurial path founding a bioinformatics/pharmacological healthcare company to identify and market innovative leading health care technology solutions.  

“I am excited to join Light AI at this important juncture as the Company transitions into commercialization of its leading AI health diagnostic and wellness solutions, says Mr. John Tse. “I have been monitoring Light AI’s research progress over the past several years and am very impressed with its AI powered medical condition diagnostic software application delivered via a mobile phone commencing with addressing Strep A infections. Light AI is well positioned to capitalize on a paradigm shift with its disruptive impactful product offering commencing with its consumer-oriented Wellness App in Q3 2025.”

Mr. Tse has been honored and nationally recognized for his outstanding contributions in supporting the development and excellence of pharmacy education at the university level; advancing the standards of healthcare delivery; providing an optimal environment for education and training for pharmacy staff to advance the standards of healthcare delivery; promoting pharmacy as a community resource in the provision of pharmacy services; and bringing the attention of government and industry partners as to the valuable contributions of community pharmacy. He is the recipient of the Canadian national Len Marks Pharmacy Advance Award in 2017 and the BC Pharmacy Association’s Lifetime Achievement Award which recognizes and honors pharmacists who have made significant, ongoing contributions to the pharmacy profession and its members in British Columbia, demonstrating a commitment to leadership and advancement.

Share Contractual Resale Restriction Commencement Date corrected to January 8, 2025

The Company also announced that the contractual resale restrictions of certain common shares issued upon the completion of the business combination completed on December 13, 2024 have been corrected from December 13, 2024 to the date upon which the common shares of the Company commenced trading on the Cboe CA Exchange, being January 8, 2025 with the related contractual resale restriction dates adjusted accordingly.

About Light AI Inc. (CBOE CA: ALGO / FSE: 0HC / OTCQB: OHCFF)

Light AI Inc. is a technology Company focused on developing artificial intelligence health diagnostic solutions. Light AI is developing a technology platform which represents the next generation of patient management: it applies AI algorithms to smartphone images—starting with images of Strep A—to identify the disease in seconds. Its patented, app-based solution requires no swabs, lab tests or proprietary hardware of any kind—its hardware platform is the 4.5 billion smartphones that exist in the world today. Light AI is at the forefront of developing innovative diagnostic solutions aimed at improving healthcare delivery worldwide. Their cutting-edge AI powered technology offers rapid, accurate, and cost-effective diagnostic tools designed to address critical healthcare challenges.

In pre-FDA validation studies, Light AI’s algorithm demonstrated remarkable accuracy in differentiating between viral and bacterial pharyngitis, specifically targeting Group A Streptococcus (GAS). The algorithm achieved a 96.57% accuracy rate and attained a Negative Predictive Value of 100%, indicating its high reliability in confirming the absence of Streptococcus A infection. Viral and GAS pharyngitis affects over 600 million people annually worldwide. If left untreated, GAS pharyngitis can lead to serious complications such as Rheumatic Heart Disease (RHD), which imposes a global economic burden exceeding $1 trillion annually. Light AI’s technology offers a significant advancement in the accurate and timely diagnosis of GAS pharyngitis, potentially reducing the incidence of RHD and its associated costs. Light AI’s approach to applying AI to smartphone images can be expanded to other throat conditions, as well as other areas of analysis, such as the human eye and skin. Light AI’s vision is to combine the smartphone with AI in-the-Cloud to create a Digital Clinical Lab that provides quick and accessible diagnosis for countless conditions that today require expensive and time-consuming imaging or lab processes.

ON BEHALF OF THE COMPANY

“George Reznik”

George Reznik
Chief Financial Officer

Website: https://light.ai/
LinkedIn: LinkedIn/company/Light AI
X (Formerly Twitter): @lightaihealth

Forward-Looking Information:

This news release includes information, statements, beliefs and opinions which are forward-looking, and which reflect current estimates, expectations and projections about future events, including, but not limited to, the appointment of John Tse as Vice President, Business Development, the Company’s commercialization initiatives and other statements that contain words such as “believe,” “expect,” “project,” “should,” “seek,” “anticipate,” “will,” “intend,” “positioned,” “risk,” “plan,” “may,” “estimate” or, in each case, their negative and words of similar meaning. By its nature, forward-looking information involves a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking information. These risks, uncertainties and assumptions could adversely affect the outcome of the plans and events described herein. Readers should not place undue reliance on forward-looking information, which is based on the information available as of the date of this news release.  For a list of the factors that may affect any of the Company’s forward-looking statements, please refer to the Company’s annual information form dated February 26, 2025 and other filings made by the Company with the Canadian securities regulatory authorities (which may be viewed under its SEDAR+ profile at www.sedarplus.ca). Light AI disclaims any intention or obligation to update or revise any forward-looking information contained in this new release, whether as a result of new information, future events or otherwise, unless required by applicable law. The forward-looking information included in this news release is expressly qualified in its entirety by this cautionary statement.

SOURCE Light AI Inc.